IDEX Raises 2026 Outlook After Strong Q1 on Orders and Margin Gains
Leaders credit a larger order book in the Health & Science Technologies segment.
Overview
- IDEX lifted its full-year forecast after reporting a stronger first quarter.
- Organic sales grew 5% and adjusted EBITDA margin reached 26%, with orders up about 10% year over year.
- Management now targets 3% to 4% organic growth for 2026, anchored by a thicker HST backlog that supports growth into 2027.
- The HST segment led results, driven by demand tied to data centers, semiconductor manufacturing, space projects, and defense programs.
- The company is advancing its 8020 strategy by co-engineering critical components for space and defense, and FMT logged 9% organic order growth on water and pump demand.